Radiotherapy compliance is maintained with hyprofractionation and concurrent cetuximab in locally advanced head and neck cancer

被引：8
|
作者：
Chan, Andrew [1 ]
Teoh, Daien [1 ]
Singhera, Paul [1 ]
Hartley, Andrew [1 ]
机构：
[1] Queen Elizabeth Hosp, Ctr Canc, Birmingham B15 2TH, W Midlands, England
来源：
RADIOTHERAPY AND ONCOLOGY | 2009年 / 93卷 / 03期
关键词：
SQUAMOUS-CELL CARCINOMA;
D O I：
10.1016/j.radonc.2009.05.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：654 / 654
页数：1
相关论文
共 50 条
  • [41] Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study
    Jeong, Il Seok Daniel
    Mo, Huan
    Nguyen, Anthony
    Chong, Esther G.
    Tsai, Hsin Hsiang Clarence
    Moyers, Justin
    Kim, Matthew
    Lacy, Curtis
    Shah, Vivek
    Lau, Eric
    Xu, Yi
    Cao, Huynh
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2020, 9 (01)
  • [42] A Comparative Prospective Study Between Conventional Chemo-Radiotherapy and Pure Accelerated Radiotherapy With Concurrent Chemotherapy for the Treatment of Locally Advanced Head and Neck Cancer
    Das, Sumana M.
    Roy, Niladri
    Singh, Dharmendra
    Sardar, Pritam Kumar
    Das, Siddhartha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [43] IMRT Reirradiation with Concurrent Cetuximab Immunotherapy in Recurrent Head and Neck Cancer
    Zwicker, Felix
    Roeder, Falk
    Thieke, Christian
    Timke, Carmen
    Muenter, Marc W.
    Huber, Peter E.
    Debus, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (01) : 32 - 38
  • [44] Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkers
    Tan, E. -H.
    Goh, C.
    Lim, W. T.
    Soo, K. C.
    Khoo, M. L.
    Tan, T.
    Tan, D. S. W.
    Ang, M. K.
    Ng, Q. S.
    Tan, P. H.
    Lim, A.
    Hwang, J.
    Teng, Y. H. F.
    Lim, T. H.
    Tan, S. H.
    Baskaran, N.
    Hui, K. M.
    ANNALS OF ONCOLOGY, 2012, 23 (04) : 1010 - U10
  • [45] Prospective Trial of Synchronous Bevacizumab, Erlotinib, and Concurrent Chemoradiation in Locally Advanced Head and Neck Cancer
    Yoo, David S.
    Kirkpatrick, John P.
    Craciunescu, Oana
    Broadwater, Gloria
    Peterson, Bercedis L.
    Carroll, Madeline D.
    Clough, Robert
    MacFall, James R.
    Hoang, Jenny
    Scher, Richard L.
    Esclamado, Ramon M.
    Dunphy, Frank R.
    Ready, Neal E.
    Brizel, David M.
    CLINICAL CANCER RESEARCH, 2012, 18 (05) : 1404 - 1414
  • [46] Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy
    Lucas Maahs
    Ahmed I. Ghanem
    Radhika Gutta
    Amy Tang
    Swarn Arya
    Zaid Al Saheli
    Haythem Ali
    Steven Chang
    Samantha Tam
    Vivian Wu
    Farzan Siddiqui
    Jawad Sheqwara
    BMC Cancer, 22
  • [47] Cetuximab in head and neck cancer
    Parikh, P. M.
    Bhattacharyya, G. S.
    Vora, A.
    INDIAN JOURNAL OF CANCER, 2011, 48 (02) : 145 - 147
  • [48] Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy
    Maahs, Lucas
    Ghanem, Ahmed I.
    Gutta, Radhika
    Tang, Amy
    Arya, Swarn
    Al Saheli, Zaid
    Ali, Haythem
    Chang, Steven
    Tam, Samantha
    Wu, Vivian
    Siddiqui, Farzan
    Sheqwara, Jawad
    BMC CANCER, 2022, 22 (01)
  • [49] Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy
    Liu, Jie
    Zhang, Ye
    Li, Zhengjiang
    Liu, Shaoyan
    Li, Huizheng
    Xu, Zhengang
    RADIATION ONCOLOGY, 2017, 12
  • [50] Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (Head and neck cancer: ImmunoChemo and Radiotherapy with Erbitux) - a multicenter phase IV trial
    Habl, G.
    Potthoff, K.
    Haefner, M. F.
    Abdollahi, A.
    Hassel, J. C.
    Boller, E.
    Indorf, M.
    Debus, J.
    BMC CANCER, 2013, 13
12345